Glaucoma News

SAN DIEGO — Trimming or removing the CyPass micro-stent is recommended for patients who are experiencing endothelial cell loss, while regular monitoring is recommended for CyPass patients still doing well, according to a speaker here.

SAN DIEGO — Marijuana is not recommended for glaucoma treatment, but with its increasing acceptance, clinicians need to be ready for patients to ask about it, Anurag Shrivastava, MD, said at Glaucoma Subspecialty Day at the American Society of Cataract and Refractive Surgery annual meeting.

Optometrists in Maryland will be permitted to independently treat glaucoma, remove foreign bodies, order lab tests and prescribe all topical drugs and most orals upon completion of a 10-hour education course as a result of an update to the state’s optometry practice law.

SAN DIEGO ― At the Ophthalmology Innovation Summit, Sean Ianchulev, MD, MPH, CEO of Eyenovia, discusses the company’s technology in development for mydriasis, as well as glaucoma and myopia treatments.

VANCOUVER, British Columbia — Use of MicroPulse transscleral cyclophotocoagulation in patients after keratoplasty resulted in IOP control and minimal complications, according  to a presentation here at the Association for Research in Vision and Ophthalmology meeting.

VANCOUVER, British Columbia — Researchers found no significant differences in IOP elevations in patients treated with three different anti-VEGF agents, according to a poster presented here at the Association for Research in Vision and Ophthalmology meeting.

A new hypotensive agent that could potentially enrich the armamentarium of glaucoma medications showed efficacy and safety in phase 2 trials.

Nikitha Reddy, MD , and colleagues conducted a retrospective cross-sectional study using the 2005-2008 National Health and Nutrition Examination Survey (NHANES).

VANCOUVER, British Columbia — At the Association for Research in Vision and Ophthalmology meeting, Jella An, MD, assistant professor of ophthalmology at the University of Missouri and director of glaucoma at the Mason Eye Institute, discusses findings of a meta-analysis looking at laser settings and potential outcomes of MicroPulse trans-scleral cyclophotocoagulation in adult patients with glaucoma. Drawing from the results of the study, An cites the need for standardizing techniques and minimizing variability in laser settings to optimize prognostic capabilities.

Low nocturnal diastolic blood pressure and nocturnal diastolic blood pressure dip significantly increase the risk of visual field progression in patients with normal tension glaucoma, according to a study.